tert-butylhydroperoxide has been researched along with efavirenz in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bumpus, NN; Hollenberg, PF | 1 |
| Amunugama, H; Ballou, DP; Hollenberg, PF; Kenaan, C; Sridar, C; Zhang, H | 1 |
2 other study(ies) available for tert-butylhydroperoxide and efavirenz
| Article | Year |
|---|---|
Investigation of the mechanisms underlying the differential effects of the K262R mutation of P450 2B6 on catalytic activity.
Topics: Alkynes; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Benzphetamine; Binding Sites; Catalysis; Cyclopropanes; Cytochrome P-450 CYP2B1; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Cytochromes b5; Escherichia coli; Ethinyl Estradiol; Humans; Kinetics; Molecular Structure; Mutation; NADPH-Ferrihemoprotein Reductase; Oxidants; Oxidoreductases, N-Demethylating; Protein Binding; Spectrophotometry, Ultraviolet; tert-Butylhydroperoxide | 2008 |
Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex
Topics: Alkynes; Animals; Anti-HIV Agents; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Bupropion; Catalysis; Chlorocebus aethiops; COS Cells; Coumarins; Cyclopropanes; Cytochrome P-450 CYP2B6; Electron Transport; Escherichia coli; Ferric Compounds; Genetic Variation; Kinetics; Mutagenesis; Mutation; NADPH-Ferrihemoprotein Reductase; Oxidoreductases, N-Demethylating; Polymorphism, Genetic; tert-Butylhydroperoxide | 2011 |